Status: Recruiting
A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
In this study, researchers will learn more about a study drug called DT-101 in participants with Major Depressive Disorder (MDD), a form of depression. The goal of this clinical trial is to learn if DT-101 can treat depression in adults. The effect of DT-101 will be compared to placebo. A placebo looks the drug but contains no medicine. Subjects will attend the clinic for complete general health checks and to complete questionnaires.
Participants needed: 118
Trial details
Phase: Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: Draig Therapeutics LtdUpdated: Aug 12, 2026Locations: 22
Eligibility criteria
The participant is able to read, understand and communicate in the local languag... [+2]
Pregnant or breastfeeding or plans to become pregnant during the study. [+5]